February 5, 2021
The drug maker behind Epidiolex, a CBD-based medicine, is set to be acquired in a deal worth US$7.2 billion.
November 10, 2020
Cannabis stocks can be precarious, but what about cannabis ETFs? Here's a look at why investors may want to consider...
August 7, 2020
The black sheep of the Canadian industry is mounting a comeback — this week CannTrust announced its licenses have been...
August 6, 2020
INN takes a closer look at six of the biggest cannabis exchange-traded funds and how they've performed so far in...
July 8, 2020
The psychedelics and cannabis industries have significant differences, but they also have important similarities.
April 10, 2020
Cannabis is still federally illegal in the US, and currently marijuana companies are not able to access stimulus funds in...
January 16, 2020
Purpose Investments participated in the debut of the Medical Cannabis & Wellness UCITS ETF, which offers cannabis exposure to Europeans.